NO20014414L - Farmasöytisk blanding for forhindring eller behandling av sykdom assosiert med et overskudd av IL-12 produksjon - Google Patents

Farmasöytisk blanding for forhindring eller behandling av sykdom assosiert med et overskudd av IL-12 produksjon

Info

Publication number: NO20014414L
Authority: NO; Norway
Prior art keywords: prevention; excess; treatment; production; pharmaceutical composition
Prior art date: 2000-09-15

Application number

NO20014414A

Other languages

English (en)

Norwegian (no)

Other versions

NO20014414D0 (no

Inventor

Corinne Moulon

Heleen Heysteck

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-15

Filing date

2001-09-11

Publication date

2002-03-18

2001-09-11 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2001-09-11 Publication of NO20014414D0 publication Critical patent/NO20014414D0/no

2002-03-18 Publication of NO20014414L publication Critical patent/NO20014414L/no

Links

201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
230000019734 interleukin-12 production Effects 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
230000002265 prevention Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Immunology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Oncology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Toxicology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Cardiology (AREA)

NO20014414A 2000-09-15 2001-09-11 Farmasöytisk blanding for forhindring eller behandling av sykdom assosiert med et overskudd av IL-12 produksjon NO20014414L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP00402560A EP1188438A1 (en)	2000-09-15	2000-09-15	Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production

Publications (2)

Publication Number	Publication Date
NO20014414D0 NO20014414D0 (no)	2001-09-11
NO20014414L true NO20014414L (no)	2002-03-18

Family

ID=8173864

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20014414A NO20014414L (no)	2000-09-15	2001-09-11	Farmasöytisk blanding for forhindring eller behandling av sykdom assosiert med et overskudd av IL-12 produksjon

Country Status (20)

Country	Link
US (1)	US20020119967A1 (pt)
EP (1)	EP1188438A1 (pt)
JP (1)	JP2002316948A (pt)
KR (1)	KR20020021606A (pt)
CN (1)	CN1348763A (pt)
AR (1)	AR030660A1 (pt)
AU (1)	AU7033201A (pt)
BR (1)	BR0104005A (pt)
CA (1)	CA2357155A1 (pt)
CZ (1)	CZ20013275A3 (pt)
EA (1)	EA200100876A3 (pt)
HU (1)	HUP0103686A2 (pt)
IL (1)	IL145366A0 (pt)
MX (1)	MXPA01009032A (pt)
NO (1)	NO20014414L (pt)
NZ (1)	NZ514107A (pt)
PE (1)	PE20020465A1 (pt)
PL (1)	PL349682A1 (pt)
SK (1)	SK12932001A3 (pt)
WO (1)	WO2002022112A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003535148A (ja) *	2000-06-06	2003-11-25	グラクソグループリミテッド	癌の治療方法
AU2003282550C1 (en) *	2002-10-09	2008-09-25	Tolerx, Inc.	Molecules preferentially associated with effector T cells or regulatory T cells and methods of their use
CA2663436A1 (en)	2006-10-04	2008-04-10	Pfizer Products Inc.	Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
EP2262778B8 (en)	2008-03-07	2020-01-01	Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.	1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
KR101581828B1 (ko)	2008-03-07	2015-12-31	아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이	신규한 1-벤질-3-하이드록시메틸인다졸 유도체들 및 ｍｃｐ-1, ｃｘ3ｃｒ1 및 ｐ40의 발현을 기초로 한 질환들의 치료에서 이의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE59410119D1 (de) *	1993-07-02	2002-06-20	Byk Gulden Lomberg Chem Fab	Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren
FR2725719B1 (fr) *	1994-10-14	1996-12-06	Jouveinal Inst Rech	Diazepino-indoles inhibiteurs de phosphodiesterases iv
DE59610031D1 (de) *	1995-05-18	2003-02-06	Altana Pharma Ag	Cyclohexyldihydrobenzofurane
FR2746800B1 (fr) *	1996-03-29	1998-06-05	Jouveinal Inst Rech	Diazepino-indoles inhibiteurs de phosphodiesterases 4
PT936923E (pt) *	1996-11-15	2004-04-30	Kennedy Inst Of Rheumatology	Supressao de tnfalfa e il-12 em terapia
WO1998041232A2 (en) *	1997-03-18	1998-09-24	Basf Aktiengesellschaft	Compositions for modulating responsiveness to corticosteroids
FR2762841B1 (fr) *	1997-04-30	1999-07-02	Jouveinal Inst Rech	Diazepino-indolones inhibitrices de phosphodiesterases iv
FR2776660B1 (fr) *	1998-03-27	2000-05-12	Parke Davis	Diazepino-indoles de phosphodiesterases iv
DE19843793C2 (de) *	1998-09-24	2000-08-03	Gruenenthal Gmbh	Substituierte Benzamide
EP1161239B1 (en) *	1999-03-10	2004-10-20	ALTANA Pharma AG	3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis
FR2792938B1 (fr) *	1999-04-28	2001-07-06	Warner Lambert Co	NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
FR2803299B1 (fr) *	2000-01-05	2004-09-17	Warner Lambert Co	NOUVELLES PYRAZOLO [4,3-e] DIAZEPINES SUBSTITUEES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION

2000
- 2000-09-15 EP EP00402560A patent/EP1188438A1/en not_active Withdrawn
2001
- 2001-09-06 MX MXPA01009032A patent/MXPA01009032A/es unknown
- 2001-09-10 IL IL14536601A patent/IL145366A0/xx unknown
- 2001-09-10 EA EA200100876A patent/EA200100876A3/ru unknown
- 2001-09-11 SK SK1293-2001A patent/SK12932001A3/sk unknown
- 2001-09-11 NZ NZ514107A patent/NZ514107A/xx not_active Application Discontinuation
- 2001-09-11 PE PE2001000914A patent/PE20020465A1/es not_active Application Discontinuation
- 2001-09-11 NO NO20014414A patent/NO20014414L/no unknown
- 2001-09-11 CZ CZ20013275A patent/CZ20013275A3/cs unknown
- 2001-09-11 CA CA002357155A patent/CA2357155A1/en not_active Abandoned
- 2001-09-11 KR KR1020010055998A patent/KR20020021606A/ko not_active Withdrawn
- 2001-09-12 BR BR0104005-7A patent/BR0104005A/pt not_active Application Discontinuation
- 2001-09-12 CN CN01138457A patent/CN1348763A/zh active Pending
- 2001-09-12 JP JP2001277234A patent/JP2002316948A/ja active Pending
- 2001-09-12 AR ARP010104308A patent/AR030660A1/es unknown
- 2001-09-12 HU HU0103686A patent/HUP0103686A2/hu unknown
- 2001-09-12 AU AU70332/01A patent/AU7033201A/en not_active Abandoned
- 2001-09-13 WO PCT/EP2001/010590 patent/WO2002022112A2/en not_active Ceased
- 2001-09-14 PL PL01349682A patent/PL349682A1/xx not_active Application Discontinuation
- 2001-09-15 US US09/953,822 patent/US20020119967A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20020119967A1 (en)	2002-08-29
WO2002022112A9 (en)	2002-06-06
CZ20013275A3 (cs)	2002-04-17
WO2002022112A3 (en)	2004-02-26
CA2357155A1 (en)	2002-03-15
HUP0103686A2 (en)	2002-06-29
EP1188438A1 (en)	2002-03-20
EA200100876A2 (ru)	2002-04-25
JP2002316948A (ja)	2002-10-31
AU7033201A (en)	2002-03-21
CN1348763A (zh)	2002-05-15
PE20020465A1 (es)	2002-06-06
KR20020021606A (ko)	2002-03-21
HU0103686D0 (en)	2001-11-28
NZ514107A (en)	2001-09-28
IL145366A0 (en)	2002-06-30
PL349682A1 (en)	2002-03-25
NO20014414D0 (no)	2001-09-11
EA200100876A3 (ru)	2002-06-27
BR0104005A (pt)	2002-07-09
WO2002022112A2 (en)	2002-03-21
SK12932001A3 (sk)	2002-04-04
MXPA01009032A (es)	2004-11-10
AR030660A1 (es)	2003-08-27

Publication	Publication Date	Title
NO20006630D0 (no)	2000-12-22	Farmasöytisk sammensetning for behandlingen av diabetes
NO971816D0 (no)	1997-04-18	Farmasöytisk blanding for behandling av sykdommer forårsaket av IL-6 produksjon
DE60126321D1 (de)	2007-03-15	Gelsystem zur ocularen verabreichung von arzneimitteln
ATE491436T1 (de)	2011-01-15	Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
DK0721449T3 (da)	2002-04-22	Inhibitorer af beta-amyloidproteinproduktion
DE50206657D1 (de)	2006-06-08	Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
ATE269077T1 (de)	2004-07-15	Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
DE50013843D1 (de)	2007-01-18	Arzneimittel zur behandlung von darmerkrankungen
NO20033622L (no)	2003-10-06	Fremgangsmate for behandling av demyeliniserende sykdommer eller tilstander
DE60229287D1 (de)	2008-11-20	Pharmazeutische zubereitung zur oralen verwendung von heparin und seinen derivaten
DE69108143D1 (de)	1995-04-20	Rotogranulate und geschmacksabdeckende Überzüge zur Herstellung pharmazeutischer Kautabletten.
NO20005000D0 (no)	2000-10-04	FremgangsmÕte for fremstilling av rÕstoffer for glassfremstilling
NO20020784D0 (no)	2002-02-18	Medikament for behandling av brudd
NO20014414D0 (no)	2001-09-11	Farmasöytisk blanding for forhindring eller behandling av sykdom assosiert med et overskudd av IL-12 produksjon
EE200100544A (et)	2003-02-17	15-lülilised 8a- ja 9a-laktaamid, nende valmistamismeetod ja farmatseutiline kompositsioon
NO20014777D0 (no)	2001-10-01	Fremgangsmåte for behandling av flyveaske under anvendelse av saltsyre
FR2831169B1 (fr)	2003-12-12	Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NO20012612L (no)	2001-07-17	Isonipecotamider for behandlingen av integrin-formidlede sykdommer
EE04941B1 (et)	2007-12-17	Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamine
ITMI992048A0 (it)	1999-10-01	Procedimento stereoselettivo per la preparazione di endo-3-amminoazabi cicloalcani
HUP0301971A3 (en)	2007-09-28	Uses of thaliporphine or its derivatives for producing pharmaceutical compositions suitable for treating cardiac diseases and the compounds
NO20021710L (no)	2002-04-11	Anvendelse av 2-amino-3,4-dihydro-kinazoliner for fremstilling av et medikament for behandling eller profylakse avsykdommer bevirket av iskemiske tilstander
NO20020328D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
MA27088A1 (fr)	2004-12-20	Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compostions pharmaceutiques qui les contiennent
NO20020327D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol